Oryzon Genomics is a clinical stage biopharmaceutical company that discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases.
Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products.
PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
Mosaic ImmunoEngineering (formerly known as Patriot Scientific Corporation) is a biotechnology company focused on bridging immunology and engineering to develop immunotherapies to treat and prevent cancer and infectious diseases.